ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Imraldi 40 mg/0.8 ml, Injektionslösung in einer Fertigspritze - 2
67427002 Samsung Bioepis CH GmbH
Imraldi 40 mg/0.8 ml, Injektionslösung in einer Fertigspritze03.04.2020
  03.04.2020
Adalimumab (L04AB04) 
WHO-DDD 
07.15.2
07.15. 
B  
Yes 
IPCI
742.20Yes
    
10 %823.50
7680674270027Biotechnologika
7771893 
Composition
adalimumabum 40 mg, natrii citras dihydricus, acidum citricum monohydricum, histidinum, histidini hydrochloridum monohydricum, sorbitolum 20 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.375 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Adalimumab40mg / 0.8ml
BAG: Active AgentDose
Adalimumab40 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Histidin Hydrochloride Monohydrate 
Histidine 
Natrii Citras Dihydricus 
Polysorbatum 20 
Sorbitol20mg / 0.8ml
 
Source
Data was imported : 07.01.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home